ANI Pharmaceuticals
$50.57
13
+$0.76+1.53% Friday 21:00
Statistics
Day High
51.26
Day Low
49.61
52W High
65.89
52W Low
36.36
Volume
160,791
Avg. Volume
208,356
Mkt Cap
1.03B
P/E Ratio
79.88
Dividend Yield
-
Dividend
-
Upcoming
Earnings
7MarExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Next
0.13
0.51
0.9
1.28
Expected EPS
0.78
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ANIP. It's not an investment recommendation.
Analyst Ratings
71.67$Average Price Target
The highest estimate is $73.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%
About
Health Technology
Pharmaceuticals: Other
Manufacturing
Biological Product (except Diagnostic) Manufacturing
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Show more...
CEO
Patrick Walsh
Employees
601
Country
US
ISIN
US00182C1036
WKN
000A1W15D